50
Participants
Start Date
September 30, 2004
Study Completion Date
April 30, 2007
Infliximab
Etanercept
Adalimumab
Rigshospitalet, Copenhagen
Bispebjerg Hospital, Copenhagen
Glostrup Hospital, Glostrup Municipality
Hvidovre University Hospital, Hvidovre
Herlev Hospital, Herlev
Gentofte Hospital, Gentofte Municipality
Graasten Gighospital, Gråsten
Vejle Sygehus, Vejle
Horsens Sygehus, Horsens
Hvidovre University Hospital
OTHER